The ICR is led by our Interim Chief Executive, Professor Paul Workman – an expert in cancer drug discovery. We lead the world at isolating cancer-related genes and discovering new targeted cancer drugs. Together with our hospital partner The Royal Marsden, we are rated in the top four centres for cancer research and treatment worldwide.
We are a college of the University of London, providing postgraduate higher education of international distinction. The ICR has charitable status and relies on support from partner organisations, charities, donors and the general public.